Research Site

Sayama-shi, 350-1305

1 studies enrolling now · 7 studies all time

What they study most

Acute Ischaemic Stroke, Atherothrombosis, Cardiovascular Death, Chronic Heart Failure With Reduced Ejection Fraction (HFrEF), Diabetes Mellitus, Type 2, Diabetic Kidney Disease, Heart Failure With Reduced Ejection Fraction (HFrEF), Myocardial Infarction, Rheumatoid Arthritis, Stroke, Transient Ischaemic Attack

Studies at this site

• A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis — Recruiting now
• A Phase 2b Diabetic Kidney Disease Study — Completed
• DETERMINE-reduced - Dapagliflozin Effect on Exercise Capacity Using a 6-minute Walk Test in Patients With Heart Failure With Reduced Ejection Fraction — Completed
• Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure — Completed
• A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus — Completed
• [SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES] — Completed
• Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin — Completed